Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Hosea NA"'
Autor:
Zhu Zhou, Shi Manli, Hu Wenyue, Estrella Heather, Engebretsen Jon, Nichols Tim, Briere David, Hosea Natilie, Los Gerrit, Rejto Paul A, Fanjul Andrea
Publikováno v:
BMC Genomics, Vol 13, Iss 1, p 355 (2012)
Abstract Background The androgen receptor plays a critical role throughout the progression of prostate cancer and is an important drug target for this disease. While chromatin immunoprecipitation coupled with massively parallel sequencing (ChIP-Seq)
Externí odkaz:
https://doaj.org/article/7cc37779c83245cb9ff3d3e41a4a2014
Autor:
Aguirre SA; 1Drug Safety Research & Development, Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, USA., Liu L, Hosea NA, Scott W, May JR, Burns-Naas LA, Randolph S, Denlinger RH, Han B
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2014; Vol. 42 (2), pp. 422-34. Date of Electronic Publication: 2013 May 07.
Autor:
Nair SK; Medicinal Chemistry, Pfizer Global R&D, San Diego, CA 92121, USA. sajiv.k.nair@pfizer.com, Matthews JJ, Cripps SJ, Cheng H, Hoffman JE, Smith C, Kupchinsky S, Siu M, Taylor WD, Wang Y, Johnson TO, Dress KR, Edwards MP, Zhou S, Hosea NA, Lapaglia A, Kang P, Castro A, Ermolieff J, Fanjul A, Vogel JE, Rejto P, Dalvie D
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2013 Apr 15; Vol. 23 (8), pp. 2344-8. Date of Electronic Publication: 2013 Feb 24.
Autor:
Jones HM; Department of Pharmacokinetics, Dynamics and Metabolism, Pfizer Worldwide RD, Sandwich, UK. hannah.jones@pfizer.com, Gardner IB, Collard WT, Stanley PJ, Oxley P, Hosea NA, Plowchalk D, Gernhardt S, Lin J, Dickins M, Rahavendran SR, Jones BC, Watson KJ, Pertinez H, Kumar V, Cole S
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2011 May; Vol. 50 (5), pp. 331-47.
Autor:
Hosea NA; Pharmacokinetics, Dynamics & Metabolism, Pfizer, Inc., 10646 Science Center Dr., San Diego, CA 92121, USA. natilie.hosea@pfizer.com
Publikováno v:
Current topics in medicinal chemistry [Curr Top Med Chem] 2011; Vol. 11 (4), pp. 351-7.
Autor:
Siu M; Discovery Chemistry, Pfizer Global Research and Development, 10770 Science Center Drive, San Diego, CA 92121, United States. siu.michael@gene.com, Johnson TO, Wang Y, Nair SK, Taylor WD, Cripps SJ, Matthews JJ, Edwards MP, Pauly TA, Ermolieff J, Castro A, Hosea NA, LaPaglia A, Fanjul AN, Vogel JE
Publikováno v:
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2009 Jul 01; Vol. 19 (13), pp. 3493-7. Date of Electronic Publication: 2009 May 07.
Autor:
Hosea NA; Pfizer Inc, Department of Pharmacokinetics, Dynamics & Metabolism, San Diego, CA 92121, USA. natilie.hosea@pfizer.com, Collard WT, Cole S, Maurer TS, Fang RX, Jones H, Kakar SM, Nakai Y, Smith BJ, Webster R, Beaumont K
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2009 May; Vol. 49 (5), pp. 513-33. Date of Electronic Publication: 2009 Mar 19.
Autor:
Doran A; Pharmacokinetics, Dynamics, and Drug Metabolism, Pfizer Global Research and Development, Groton Laboratories, Groton, CT 06340, USA. angela_c_doran@groton.pfizer.com, Obach RS, Smith BJ, Hosea NA, Becker S, Callegari E, Chen C, Chen X, Choo E, Cianfrogna J, Cox LM, Gibbs JP, Gibbs MA, Hatch H, Hop CE, Kasman IN, Laperle J, Liu J, Liu X, Logman M, Maclin D, Nedza FM, Nelson F, Olson E, Rahematpura S, Raunig D, Rogers S, Schmidt K, Spracklin DK, Szewc M, Troutman M, Tseng E, Tu M, Van Deusen JW, Venkatakrishnan K, Walens G, Wang EQ, Wong D, Yasgar AS, Zhang C
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2005 Jan; Vol. 33 (1), pp. 165-74. Date of Electronic Publication: 2004 Oct 22.